{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T13:50:40Z","timestamp":1770990640196,"version":"3.50.1"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["neurology.org"],"crossmark-restriction":true},"short-container-title":["Neurology"],"published-print":{"date-parts":[[1996,7]]},"DOI":"10.1212\/wnl.47.1.196","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T13:21:25Z","timestamp":1336915285000},"page":"196-201","update-policy":"https:\/\/doi.org\/10.1212\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":53,"title":["A newly identified polymorphism in the apolipoprotein E enhancer gene region is associated with Alzheimer's disease and strongly with the epsilon 4 allele"],"prefix":"10.1212","volume":"47","author":[{"given":"S.","family":"Mui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Briggs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. B.","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Gomez-Isla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. W.","family":"Rebeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. T.","family":"Hyman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","first-page":"1","volume":"43","year":"1993","unstructured":"Saunders A, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E allele epsilon 4 with the late-onset familial and sporadic Alzheimer disease. Neurology 1993;43:1467-1472.","journal-title":"Neurology"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.1.1"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)91879-Q"},{"key":"e_1_3_1_5_2","first-page":"4","volume":"175","year":"1994","unstructured":"West HL, Rebeck GW, Hyman BT. Frequency of the apolipoprotein E epsilon 2 allele is diminished in sporadic Alzheimer disease. Neurosci Lett 1994;175:46-48.","journal-title":"Neurosci Lett"},{"key":"e_1_3_1_6_2","first-page":"6","volume":"54","year":"1994","unstructured":"Tsai M-S, Tangalos EG, Petersen RC, et al. Apolipoprotein E: risk factor for Alzheimer disease. Am J Hum Genet 1994;54:643-649.","journal-title":"Am J Hum Genet"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410390104"},{"key":"e_1_3_1_8_2","first-page":"5","volume":"11","year":"1993","unstructured":"Rebeck GW, Reiter JS, Strickland DK, Hyman BT. Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron 1993;11:575-580.","journal-title":"Neuron"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng0594-1"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.261.5117.9"},{"key":"e_1_3_1_11_2","first-page":"6","volume":"240","year":"1988","unstructured":"Mahley RW. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 1988;240:622-630.","journal-title":"Science"},{"key":"e_1_3_1_12_2","first-page":"3","volume":"28","year":"1986","unstructured":"Ordovas JM, Litwack-Klein L, Wilson PWF, et al. Apolipoprotein E isoform phenotyping methodology and population frequency with identification of apoE1 and apoE5 isoforms. J Lipid Res 1986;28:371-380.","journal-title":"J Lipid Res"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.44.1.1"},{"key":"e_1_3_1_14_2","first-page":"1","volume":"21","year":"1995","unstructured":"Hyman BT, Gomez-Isla T, Briggs M, et al. Influence of apoE genotype on developing cognitive impairment in the general population. Soc Neurosci 1995;21:1008.","journal-title":"Soc Neurosci"},{"key":"e_1_3_1_15_2","first-page":"4","volume":"168","year":"1990","unstructured":"Dong LM, Yamamura T, Yamamoto A. Enhanced binding activity of an apolipoprotein E mutant, apoE5, to LDL receptors on human fibroblasts. Biochem Biophys Res Commun 1990;168:409-414.","journal-title":"Biochem Biophys Res Commun"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2275(20)41877-2"},{"key":"e_1_3_1_17_2","first-page":"6","volume":"259","year":"1984","unstructured":"McLean JW, Elshourbagy NA, Chang DJ, Mahley RW, Taylor JM. Human apolipoprotein E mRNA: cDNA cloning and nucleotide sequencing of a new variant. J Biol Chem 1984;259:6498-6504.","journal-title":"J Biol Chem"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI110946"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI110223"},{"key":"e_1_3_1_20_2","first-page":"9","volume":"52","year":"1993","unstructured":"van den Maagdenberg AM, Weng W, de Bruijn IH, et al. Characterization of five new mutants in the carboxyl-terminal domain of human apolipoprotein E: no consegregation with severe hyperlipidemia. Am J Hum Genet 1993;52:937-946.","journal-title":"Am J Hum Genet"},{"key":"e_1_3_1_21_2","first-page":"2","volume":"264","year":"1989","unstructured":"Wardell MR, Weisgraber KH, Havekes LM, Rall SC Jr. Apolipoprotein E3-Leiden contains a seven-amino acid insertion that is a tandem repeat of residues 121-127. J Biol Chem 1989;264:21205-21210.","journal-title":"J Biol Chem"},{"key":"e_1_3_1_22_2","first-page":"5","volume":"32","year":"1991","unstructured":"Wardell MR, Rall SC Jr, Schaefer EJ, et al. Two apolipoprotein E5 variants illustrate the importance of the position of additional positive charge on receptor-binding activity. J Lipid Res 1991;32:521-528.","journal-title":"J Lipid Res"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2275(20)42755-5"},{"key":"e_1_3_1_24_2","unstructured":"Betard C Gee M Robitaille Y Cholette AL Roy P Gauvreau D. Linkage disequilibrium between a newly identified polymorphism in the apoE enhancer gene region and apoE epsilon 4 allele in Alzheimer patients. In: Roses A Weisgraber K Christen Y eds. Apolipoprotein E and Alzheimer's disease. New York: Springer-Verlag (in press)."},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)57345-8"},{"key":"e_1_3_1_26_2","first-page":"9","volume":"34","year":"1984","unstructured":"McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA group under the auspices of Dept. of HHS Task Force on Alzheimer's disease. Neurology 1984;34:939-944.","journal-title":"Neurology"},{"key":"e_1_3_1_27_2","first-page":"7","volume":"114","year":"1968","unstructured":"Blessed G, Tomlinson BE, Roth M. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry 1968;114:797-811.","journal-title":"Br J Psychiatry"},{"key":"e_1_3_1_28_2","first-page":"2","volume":"1","year":"1991","unstructured":"Colsher PL, Wallace RB. Longitudinal application of cognitive function measures in a defined population of community-dwelling elders. Ann Epidemiol 1991;1:215-230.","journal-title":"Ann Epidemiol"},{"key":"e_1_3_1_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/0895-4356(94)90029-9"},{"key":"e_1_3_1_30_2","unstructured":"Coroni-Huntley J Brock D Ostfeld A et al. National Institute on Aging Established Populations for Epidemiologic Studies of the Elderly: resource book. Bethesda: National Institutes of Health 1986."},{"key":"e_1_3_1_31_2","first-page":"5","volume":"31","year":"1990","unstructured":"Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplifications and cleavage with Hha 1. J Lipid Res 1990;31:545-548.","journal-title":"J Lipid Res"},{"key":"e_1_3_1_32_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.24.1.1"},{"key":"e_1_3_1_33_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.1.1"},{"key":"e_1_3_1_34_2","first-page":"2","volume":"269","year":"1994","unstructured":"Dong LM, Wilson C, Wardell MR, et al. Human apolipoprotein E: role of arginine 61 in mediating the lipoprotein preferences of the E3 and E4 isoforms. J Biol Chem 1994;269:22358-22365.","journal-title":"J Biol Chem"},{"key":"e_1_3_1_35_2","first-page":"5","volume":"3","year":"1994","unstructured":"Chartier-Harlin M-C, Parfitt M, Legrain S, et al. Apolipoprotein E, epsilon 4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region. Hum Mol Genet 1994;3:569-574.","journal-title":"Hum Mol Genet"}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.47.1.196","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T10:26:26Z","timestamp":1711535186000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.47.1.196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,7]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1996,7]]}},"alternative-id":["10.1212\/WNL.47.1.196"],"URL":"https:\/\/doi.org\/10.1212\/wnl.47.1.196","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,7]]}}}